EUVIMEDEUVIMED entdecken
Crossref

Assessment of Perioperative Transfusion Risk for Benign Minimally Invasive Hysterectomy Utilizing the ACS-NSQIP

Sarah Ashmore iD, Jinxuan Shi, Sarah Collins

International Urogynecology Journal · 2025

DOI: 10.1007/s00192-025-06113-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Sarah Ashmore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Urogynecology and Reconstructive Pelvic Surgery, University of Chicago, Chicago, IL, USA. sleilaniashmore@gmail.com. Hauptthemen laut MEDLINE: Hysterectomy, Blood Transfusion, Pelvic Organ Prolapse. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND HYPOTHESIS: Routine preoperative laboratory testing is commonly required prior to minimally invasive hysterectomy (MIH) for pelvic organ prolapse (POP), despite limited evidence for its clinical value. We aim to identify transfusion risk for MIH for POP compared with other benign indications. METHODS: Using the 2014 to 2021 American College of Surgeons National Surgical Quality Improvement Program Gynecology Participant Use Data File, we performed a retrospective cohort study to determine the risk of perioperative blood transfusion following MIH for benign indications. MIH were identified using CPT codes, and surgical indications were classified according to ICD-9 and -10 codes. Gynecological malignancy risk-reducing indications were categorized as prophylactic. Hysterectomy routes included total laparoscopic hysterectomy, laparoscopic supracervical hysterectomy, laparoscopic assisted vaginal hysterectomy, and vaginal hysterectomy. Hysterectomies for malignancy were excluded. Perioperative transfusions were defined as those given intraoperatively or within 30 days postoperatively. RESULTS: A total of 282,124 patients underwent MIH for benign gynecological indications. Patients undergoing MIH for POP compared with other benign indications were older, had lower BMI, and were less likely to currently smoke (p < 0.001). Overall transfusion rate for benign MIH was 1.2%, and transfusion rates differed significantly by surgical indication (p < 0.001). Patients undergoing MIH for POP had a low rate of transfusion (0.7%) compared with other benign indications such as anemia (15.9%), fibroids (1.8%), and menstrual disorders (1.5%). CONCLUSIONS: Patients undergoing surgery for POP had significantly lower rates of transfusion than those with other benign indications. Aggressive preoperative precautions, including laboratory testing and redundant intravenous access, are likely excessive in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HysterectomyBlood TransfusionPelvic Organ ProlapseHumansFemaleRetrospective StudiesMiddle AgedAgedRisk AssessmentLaparoscopyAdultMinimally Invasive Surgical ProceduresRisk Factors

Stichwörter der Autor:innen

Benign hysterectomyMinimally invasive hysterectomyPerioperative transfusionPreoperative laboratory testingPreoperative testing

Autor:innen und Institutionen

  • Section of Urogynecology and Reconstructive Pelvic Surgery, University of Chicago, Chicago, IL, USA. sleilaniashmore@gmail.com.
  • Section of Urogynecology and Reconstructive Pelvic Surgery, University of Chicago, Chicago, IL, USA.

ORCID-Profile: Sarah Ashmore

Zitieren

APA

Ashmore, S., Shi, J., & Collins, S. (2025). Assessment of Perioperative Transfusion Risk for Benign Minimally Invasive Hysterectomy Utilizing the ACS-NSQIP. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06113-1

Vancouver

Ashmore S, Shi J, Collins S. Assessment of Perioperative Transfusion Risk for Benign Minimally Invasive Hysterectomy Utilizing the ACS-NSQIP. International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06113-1

BibTeX
@article{Ashmore2025,
  author = {Ashmore, Sarah and Shi, Jinxuan and Collins, Sarah},
  title = {Assessment of Perioperative Transfusion Risk for Benign Minimally Invasive Hysterectomy Utilizing the ACS-NSQIP},
  journal = {International Urogynecology Journal},
  year = {2025},
  doi = {10.1007/s00192-025-06113-1}
}
Kostenlos starten →